Nickolas Fretes1, Evan Vellios1, Akshay Sharma2, Remi M Ajiboye3,4. 1. UCLA Medical Center, 10833 LeConte Avenue, 76-119 CHS, Los Angeles, CA, 90095-6902, USA. 2. Case Western Reserve School of Medicine, 10900 Euclid Ave, Cleveland, OH, 44106, USA. 3. Sports and Spine Orthopedics, 23456 Hawthorne Blvd Suite 200, Torrance, CA, 90505, USA. RemiSpineMD@gmail.com. 4. Department of Orthopedic Surgery, Stanford Medical Center, 450 Broadway Street, MC 6342, Redwood City, CA, 94063, USA. RemiSpineMD@gmail.com.
Abstract
PURPOSE: To date, there are conflicting reports with no consensus on the influence of bisphosphonates on lumbar fusion. The goal of this study was to compare the radiographic and functional outcomes of patients that had lumbar fusion with and without bisphosphonates. METHODS: A systematic search of multiple medical reference databases was conducted for studies comparing bisphosphonate use to controls following spinal fusion. Meta-analysis was performed using the random-effects model for heterogeneity. Radiographic outcome measures included fusion rates and risk of screw loosening, cage subsidence and vertebral fracture. Functional outcomes measures included Oswestry Disability Index and visual analog scale score for back and leg pain. RESULTS: Bisphosphonate use was statistically suggestive of a higher fusion rate compared to controls (OR 2.2, 95% CI 0.87-5.56, p = 0.09). There was no difference in screw loosening rates between the bisphosphonate group and controls (OR 0.45, 95% CI 0.14-1.48, p = 0.19). However, bisphosphonate use was associated with decreased odds of cage subsidence and vertebral fractures compared to controls (cage subsidence: OR 0.29, 95% CI 0.11-0.75, p = 0.01; vertebral fracture: OR 0.18, 95% CI 0.07-0.48, p = 0.0007). CONCLUSION: Bisphosphonate use does not appear to impair successful lumbar fusion compared to controls. Additionally, bisphosphonate use was associated with decreased odds of cage subsidence and vertebral fractures compared to controls that had lumbar fusion. These slides can be retrieved under Electronic Supplementary Material.
PURPOSE: To date, there are conflicting reports with no consensus on the influence of bisphosphonates on lumbar fusion. The goal of this study was to compare the radiographic and functional outcomes of patients that had lumbar fusion with and without bisphosphonates. METHODS: A systematic search of multiple medical reference databases was conducted for studies comparing bisphosphonate use to controls following spinal fusion. Meta-analysis was performed using the random-effects model for heterogeneity. Radiographic outcome measures included fusion rates and risk of screw loosening, cage subsidence and vertebral fracture. Functional outcomes measures included Oswestry Disability Index and visual analog scale score for back and leg pain. RESULTS:Bisphosphonate use was statistically suggestive of a higher fusion rate compared to controls (OR 2.2, 95% CI 0.87-5.56, p = 0.09). There was no difference in screw loosening rates between the bisphosphonate group and controls (OR 0.45, 95% CI 0.14-1.48, p = 0.19). However, bisphosphonate use was associated with decreased odds of cage subsidence and vertebral fractures compared to controls (cage subsidence: OR 0.29, 95% CI 0.11-0.75, p = 0.01; vertebral fracture: OR 0.18, 95% CI 0.07-0.48, p = 0.0007). CONCLUSION:Bisphosphonate use does not appear to impair successful lumbar fusion compared to controls. Additionally, bisphosphonate use was associated with decreased odds of cage subsidence and vertebral fractures compared to controls that had lumbar fusion. These slides can be retrieved under Electronic Supplementary Material.
Authors: Russel C Huang; Safdar N Khan; Harvinder S Sandhu; Joshua A Metzl; Frank P Cammisa; Fengyu Zheng; Andrew A Sama; Joseph M Lane Journal: Spine (Phila Pa 1976) Date: 2005-11-15 Impact factor: 3.468
Authors: Daniel Lubelski; Theodore J Choma; Michael P Steinmetz; James S Harrop; Thomas E Mroz Journal: Neurosurgery Date: 2015-10 Impact factor: 4.654
Authors: Ronald A Lehman; Timothy R Kuklo; Brett A Freedman; Jerry R Cowart; Mark G Mense; K Daniel Riew Journal: Spine J Date: 2004 Jan-Feb Impact factor: 4.166